|
|
||||||||
CUTTING EDGE |
Department of Immunology, Imperial College School of Medicine, Hammersmith Hospital, London, United Kingdom
The CD48 molecule belongs to a subfamily of the Ig superfamily that also includes the CD2, CD58, 2B4, Signaling lymphocyte activation molecule (SLAM), and Ly-9 molecules. Receptor-ligand interactions are known to occur between several members of this family, and these interactions can strengthen cell to cell adhesion. In mice, the CD48 molecule can bind to CD2. To search for additional ligands of murine CD48, we have generated a chimeric fusion protein consisting of the extracellular domain of murine CD48 and the C region of human IgG1. The results of immunofluorescence and immunoprecipitation experiments in which this reagent was used identify the 2B4 molecule as a novel counter-receptor of CD48.
This article has been cited by other articles:
![]() |
L. K. Chlewicki, C. A. Velikovsky, V. Balakrishnan, R. A. Mariuzza, and V. Kumar Molecular Basis of the Dual Functions of 2B4 (CD244) J. Immunol., June 15, 2008; 180(12): 8159 - 8167. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Wahle, K. H. T. Paraiso, R. D. Kendig, H. R. Lawrence, L. Chen, J. Wu, and W. G. Kerr Inappropriate Recruitment and Activity by the Src Homology Region 2 Domain-Containing Phosphatase 1 (SHP1) Is Responsible for Receptor Dominance in the SHIP-Deficient NK Cell J. Immunol., December 15, 2007; 179(12): 8009 - 8015. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Vacca, G. Pietra, M. Falco, E. Romeo, C. Bottino, F. Bellora, F. Prefumo, E. Fulcheri, P. L. Venturini, M. Costa, et al. Analysis of natural killer cells isolated from human decidua: evidence that 2B4 (CD244) functions as an inhibitory receptor and blocks NK-cell function Blood, December 15, 2006; 108(13): 4078 - 4085. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bhat, P. Eissmann, J. Endt, S. Hoffmann, and C. Watzl Fine-tuning of immune responses by SLAM-related receptors J. Leukoc. Biol., March 1, 2006; 79(3): 417 - 424. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. T. Bryceson, M. E. March, D. F. Barber, H.-G. Ljunggren, and E. O. Long Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells J. Exp. Med., October 3, 2005; 202(7): 1001 - 1012. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Assarsson, T. Kambayashi, C. M. Persson, B. J. Chambers, and H.-G. Ljunggren 2B4/CD48-Mediated Regulation of Lymphocyte Activation and Function J. Immunol., August 15, 2005; 175(4): 2045 - 2049. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Martin, J. M. Del Valle, I. Saborit, and P. Engel Identification of Grb2 As a Novel Binding Partner of the Signaling Lymphocytic Activation Molecule-Associated Protein Binding Receptor CD229 J. Immunol., May 15, 2005; 174(10): 5977 - 5986. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. V. Vaidya, S. E. Stepp, M. E. McNerney, J.-K. Lee, M. Bennett, K.-M. Lee, C. L. Stewart, V. Kumar, and P. A. Mathew Targeted Disruption of the 2B4 Gene in Mice Reveals an In Vivo Role of 2B4 (CD244) in the Rejection of B16 Melanoma Cells J. Immunol., January 15, 2005; 174(2): 800 - 807. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Munitz, I. Bachelet, S. Fraenkel, G. Katz, O. Mandelboim, H.-U. Simon, L. Moretta, M. Colonna, and F. Levi-Schaffer 2B4 (CD244) Is Expressed and Functional on Human Eosinophils J. Immunol., January 1, 2005; 174(1): 110 - 118. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Mooney, J. Klem, C. Wulfing, L. A. Mijares, P. L. Schwartzberg, M. Bennett, and J. D. Schatzle The Murine NK Receptor 2B4 (CD244) Exhibits Inhibitory Function Independent of Signaling Lymphocytic Activation Molecule-Associated Protein Expression J. Immunol., September 15, 2004; 173(6): 3953 - 3961. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Chen, F. Relouzat, R. Roncagalli, A. Aoukaty, R. Tan, S. Latour, and A. Veillette Molecular Dissection of 2B4 Signaling: Implications for Signal Transduction by SLAM-Related Receptors Mol. Cell. Biol., June 15, 2004; 24(12): 5144 - 5156. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Flaig, S. Stark, and C. Watzl Cutting Edge: NTB-A Activates NK Cells via Homophilic Interaction J. Immunol., June 1, 2004; 172(11): 6524 - 6527. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-M. Lee, M. E. McNerney, S. E. Stepp, P. A. Mathew, J. D. Schatzle, M. Bennett, and V. Kumar 2B4 Acts As a Non-Major Histocompatibility Complex Binding Inhibitory Receptor on Mouse Natural Killer Cells J. Exp. Med., May 3, 2004; 199(9): 1245 - 1254. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Ferlazzo and C. Munz NK Cell Compartments and Their Activation by Dendritic Cells J. Immunol., February 1, 2004; 172(3): 1333 - 1339. [Full Text] [PDF] |
||||
![]() |
S. Dhanji and H.-S. Teh IL-2-Activated CD8+CD44high Cells Express Both Adaptive and Innate Immune System Receptors and Demonstrate Specificity for Syngeneic Tumor Cells J. Immunol., October 1, 2003; 171(7): 3442 - 3450. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Watzl and E. O. Long Natural Killer Cell Inhibitory Receptors Block Actin Cytoskeleton-dependent Recruitment of 2B4 (CD244) to Lipid Rafts J. Exp. Med., January 6, 2003; 197(1): 77 - 85. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Howie, S. Okamoto, S. Rietdijk, K. Clarke, N. Wang, C. Gullo, J. P. Bruggeman, S. Manning, A. J. Coyle, E. Greenfield, et al. The role of SAP in murine CD150 (SLAM)-mediated T-cell proliferation and interferon gamma production Blood, September 26, 2002; 100(8): 2899 - 2907. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kambayashi, E. Assarsson, B. J. Chambers, and H.-G. Ljunggren Cutting Edge: Regulation of CD8+ T Cell Proliferation by 2B4/CD48 Interactions J. Immunol., December 15, 2001; 167(12): 6706 - 6710. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Chuang, P. R. Kumaresan, and P. A. Mathew 2B4 (CD244)-Mediated Activation of Cytotoxicity and IFN-{gamma} Release in Human NK Cells Involves Distinct Pathways J. Immunol., December 1, 2001; 167(11): 6210 - 6216. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Martin, X. Romero, M. A. de la Fuente, V. Tovar, N. Zapater, E. Esplugues, P. Pizcueta, J. Bosch, and P. Engel CD84 Functions as a Homophilic Adhesion Molecule and Enhances IFN-{gamma} Secretion: Adhesion Is Mediated by Ig-Like Domain 1 J. Immunol., October 1, 2001; 167(7): 3668 - 3676. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Kingsbury, L. A. Feeney, Y. Nong, S. A Calandra, C. J. Murphy, J. M. Corcoran, Y. Wang, M. R. Prabhu Das, S. J. Busfield, C. C. Fraser, et al. Cloning, Expression, and Function of BLAME, a Novel Member of the CD2 Family J. Immunol., May 1, 2001; 166(9): 5675 - 5680. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sayos, K. B. Nguyen, C. Wu, S. E. Stepp, D. Howie, J. D. Schatzle, V. Kumar, C. A. Biron, and C. Terhorst Potential pathways for regulation of NK and T cell responses: differential X-linked lymphoproliferative syndrome gene product SAP interactions with SLAM and 2B4 Int. Immunol., December 1, 2000; 12(12): 1749 - 1757. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Watzl, C. C. Stebbins, and E. O. Long Cutting Edge: NK Cell Inhibitory Receptors Prevent Tyrosine Phosphorylation of the Activation Receptor 2B4 (CD244) J. Immunol., October 1, 2000; 165(7): 3545 - 3548. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Benoit, X. Wang, H. F. Pabst, J. Dutz, and R. Tan Cutting Edge: Defective NK Cell Activation in X-Linked Lymphoproliferative Disease J. Immunol., October 1, 2000; 165(7): 3549 - 3553. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Parolini, C. Bottino, M. Falco, R. Augugliaro, S. Giliani, R. Franceschini, H. D. Ochs, H. Wolf, J.-Y. Bonnefoy, R. Biassoni, et al. X-Linked Lymphoproliferative Disease: 2b4 Molecules Displaying Inhibitory Rather than Activating Function Are Responsible for the Inability of Natural Killer Cells to Kill Epstein-Barr Virus-Infected Cells J. Exp. Med., August 7, 2000; 192(3): 337 - 346. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gonzalez-Cabrero, C. J. Wise, Y. Latchman, G. J. Freeman, A. H. Sharpe, and H. Reiser CD48-deficient mice have a pronounced defect in CD4+ T cell activation PNAS, February 2, 1999; 96(3): 1019 - 1023. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Morra, M. Simarro-Grande, M. Martin, A. S.-I. Chen, A. Lanyi, O. Silander, S. Calpe, J. Davis, T. Pawson, M. J. Eck, et al. Characterization of SH2D1A Missense Mutations Identified in X-linked Lymphoproliferative Disease Patients J. Biol. Chem., September 21, 2001; 276(39): 36809 - 36816. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |